Lotemax (loteprednol etabonate) is a new topical antiinflammatory for ophthalmic use.

Treatment with Lotemax 0.5% eye drops is indicated for postoperative inflammation following ocular surgery.

One to two drops are used four times daily beginning 24 hours after surgery, continuing for up to two weeks throughout the post-operative period.

View Lotemax drug record

Further information: Bausch & Lomb

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases